Harvard biosciences stock
WebApr 9, 2024 · Harvard Bioscience (NASDAQ:HBIO) has a market capitalization of $179.73 million and generates $113.34 million in revenue each year. The medical instruments supplier earns $-9,520,000.00 in net income (profit) each year or ($0.23) on an earnings … WebMar 10, 2024 · Harvard Bioscience stock has received a consensus rating of buy. The average rating score is and is based on 1 buy ratings, 0 hold ratings, and 0 sell ratings.
Harvard biosciences stock
Did you know?
WebHarvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and preclinical testing for drug development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and ... WebMar 16, 2024 · Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide.
Web20 hours ago · Stock Information Harvard Bioscience, Inc. Investor Relations Stock Information Symbol: Open High Low Volume Data Provided by Refinitiv. Minimum 15 … WebApr 12, 2024 · HBIO Stock Overview. Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United …
WebMar 10, 2024 · The low in the last 52 weeks of Harvard Bioscience stock was 1.99. According to the current price, Harvard Bioscience is 167.84% away from the 52-week low. What was the 52-week high for Harvard ... WebApr 14, 2024 · SEATTLE & SAN DIEGO, April 14, 2024--Phase Genomics, Inc., a leading developer of cutting-edge genomic solutions, and Element Biosciences, the developer of an innovative DNA sequencing platform ...
WebMar 24, 2024 · HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. General...
WebPursuant to the Harvard Bioscience, Inc. Second Amended and Restated 2000 Stock Option and Incentive Plan, as amended through the date hereof (the “Plan”), Harvard Bioscience, Inc. (the “Company”) hereby grants the number of Restricted Stock Units (“RSUs”) specified above (the “Award”) to the Grantee named above, subject to the … burnihhell.liveWebApr 11, 2024 · Great news for investors – Harvard Bioscience is still trading at a fairly cheap price. According to my valuation, the intrinsic value for the stock is $6.77, which is above what the market... burnig radiating chest painWebHarvard Bioscience, Inc. (HBIO) Stock Price, News, Quote & History - Yahoo Finance S&P 500 Dow 30 Nasdaq +91.09(+0.76%) Russell 2000 +2.33(+0.13%) Crude Oil -0.24( … burn igniteWebApr 7, 2024 · Harvard Bioscience (NASDAQ:HBIO) Historical Stock Chart From Mar 2024 to Apr 2024 Harvard Bioscience (NASDAQ:HBIO) Historical Stock Chart From Apr 2024 to Apr 2024 Latest HBIO Messages... burnikell houseWebFind real-time HBIO - Harvard Bioscience Inc stock quotes, company profile, news and forecasts from CNN Business. burnig smile from cpuWebPursuant to the Harvard Bioscience, Inc. Second Amended and Restated 2000 Stock Option and Incentive Plan, as amended through the date hereof (the “Plan”), Harvard … hamburger paragraph template pdfWebBased on 1 Wall Street analysts offering 12 month price targets for Harvard Bioscience in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 6.67% change from the last price of $3.75. Highest Price Target $4.00. Average Price Target $4.00. burnigseries.to